Tuesday, 12 November 2019

Drug Discovery News

  • Merck Millipore enhances bioavailability portfolio

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2012

    Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosage forms that address solubility, and PK/PD modification and targeting...Read more

  • Singapore scientists, clinicians collaborate on 8 projects

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of diseases especially prevalent amongst the Asian population. These prog...Read more

  • Boehringer Ingelheim enriches drug pipeline

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of a clinical-stage company, Funxional Therapeutics' FX125L compound and...Read more

  • China will overtake Japan in R&D spending: Report

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2013

    Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, investing billions of dollars and setting up innovation centers in a bid ...Read more

  • Astellas gets FDA nod for kidney transplant drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more

  • Global collaborations is the way forward for drug discovery

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more

  • NIH gives $2.2 mn to VaxInnate for dengue vaccine

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

    Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provided funds worth $2.2 million to US based-novel vaccine firm VaxInnate...Read more

  • Janssen to develop therapy for immunological diseases

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and commercialization, except in Japan, of ASP015K, an oral, small molecul...Read more

  • European Commission nod for Novartis' Exjade

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inade...Read more

  • CSL hemophilia therapy gets orphan drug status

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

  • John Vernachio is Arthritis Foundation research VP

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2013

    Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his new role he will provide leadership and direction to further the Arthr...Read more

  • FDA gets biomarker database license from GVK Bio

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification Group of the US FDA. The Gobiom database, which has the latest and re...Read more

  • Otsuka, Lundbeck files NDA for schizophrenia drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

  • NIH study: Diabetes drug Metformin extends life

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led...Read more

  • Accelerating drug discovery process

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

    In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platforms to develop new drugs. Many biotechnology researchers and entreprene...Read more

  • Boehringer to open $46 mn biologics plant in Shanghai

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer contract manufacturing to Chinese companies developing their own drugs....Read more

  • Recycled plastic can kill drug-resistant fungi

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research Almaden have discovered a new, potentially life-saving application f...Read more

  • Novartis liver cancer trial with Afinitor flops

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more